(Q51751625)

11 April 2018

title

Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters. (English)

1 reference

11 April 2018

0 references

1 reference

1

1 reference

11 April 2018

author name string

Gabriela Maria Sanda

series ordinal

2

1 reference

11 April 2018

Mariana Deleanu

series ordinal

3

1 reference

11 April 2018

Anca Volumnia Sima

series ordinal

4

1 reference

11 April 2018

publication date

18 September 2013

1 reference

11 April 2018

Molecular Nutrition and Food Research

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 April 2018

volume

58

1 reference

11 April 2018

issue

3

1 reference

11 April 2018

page(s)

559-568

1 reference

11 April 2018

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Recent clinical studies of the effects of lipid-modifying therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Non-every day statin administration--a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Food and food supplements with hypocholesterolemic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Natural compounds regulate energy metabolism by the modulating the activity of lipid-sensing nuclear receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Antioxidant vitamins and their use in preventing cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Assessment of antioxidant capacity of natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Probiotics: which and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Probiotic bacteria and intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Multistep mechanism of probiotic bacterium, the effect on innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Probiotics and gut health: a special focus on liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Effects of consumption of probiotics and prebiotics on serum lipid levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolisms in rats fed a high-fat and high-cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Gut microbiota in obesity and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Targeting high density lipoproteins in the prevention of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Characterization of Lactobacillus plantarum Lp27 isolated from Tibetan kefir grains: a potential probiotic bacterium with cholesterol-lowering effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Therapies targeting exogenous cholesterol uptake: new insights and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

A new, powerful player in lipoprotein metabolism: brown adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Vascular endothelial growth factor B controls endothelial fatty acid uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Role of lipid peroxidation and PPAR-δ in amplifying glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

Palmitate induces C-reactive protein expression in human aortic endothelial cells. Relevance to fatty acid–induced endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300224

21 January 2018

Identifiers

DOI

10.1002/MNFR.201300224

1 reference

11 April 2018

1 reference

11 April 2018